AXTA vs EGO

AXTA's deterministic scorecard shows a Piotroski F-Score of 4/9, indicating stable but not strong financial health, and the absence of an Altman Z-Score prevents a full distress risk assessment. The stock trades below the growth-based intrinsic value of $48.10 but above the conservative Graham Number of $22.25, suggesting mixed valuation signals. Despite solid profitability metrics like a 21.33% ROE and consistent earnings beats, revenue is contracting YoY by 2.40%, and insider activity is bearish with recent selling. Analysts recommend a 'buy' with a $36.71 target, implying moderate upside from current levels around $33.62.

EGO presents a compelling value opportunity, trading at $32.07, which is below its Graham Number ($35.08) and significantly below its growth-based intrinsic value ($74.63). While the Piotroski F-Score of 4/9 indicates only stable financial health rather than strength, the company's low Debt/Equity (0.30) and strong liquidity (Current Ratio 1.83) provide a solid safety buffer. Explosive YoY earnings growth (134.8%) and a very low Forward P/E (5.48) suggest significant upside, though this is currently offset by a bearish technical trend and recent earnings misses.